05:53 PM EDT, 10/15/2024 (MT Newswires) -- Andrew J. Schwab, 10% Owner, Director, on October 15, 2024, executed a purchase for 909,090 shares in Camp4 Therapeutics ( CAMP ) for $9,999,990. Following the Form 4 filing with the SEC, Schwab has control over a total of 2,625,145 shares of the company, with 2,625,145 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1736730/000110465924108702/xslF345X05/tm2426125-4_4seq1.xml